Label Value
DOI 10.1038/s41416-018-0349-6
TITLE Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer
TYPE article
PUBLICATION DATE
Service Status Date Last Checked
Scopus Yes 2019-05-22T02:36:27.413828
Web of Science Yes 2019-05-22T03:09:54.382645
Compendex No 2020-10-15T19:01:06.031359